Where I see patients (1)
Selected research
-
Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits.
JNCI cancer spectrum
-
RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4.
Cell reports
-
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
Cancer immunology research
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616